Abstract
Rotavirus enteritis (RVE) is a common acute intestinal infectious disease caused by rotavirus infection. It is an important cause of death in children younger than 5 years worldwide. Shenling baizhu powder (SBP), a classic traditional Chinese formulation, is one of the most popularly prescribed medicines for digestive diseases. Clinical studies have revealed the protective effects of SBP on RVE. However, the potential mechanism is still unclear. In this study, we aimed to evaluate the anti-rotavirus effect of SBP and its mechanism, focusing on the TLR4/MyD88/NF-κB signaling pathway. Our results demonstrated that, based on the inhibition of the virus-induced cytopathic effect in Caco-2 cells, the concentration for 50% of maximal effect (EC50) and selectivity index (SI) of SBP for RV-SA11 in the serum were 5.911% and 11.63, respectively. A total of 219 active compounds with oral bioavailability ≥30% and drug-likeness ≥ 0.18 were selected from the 10 ingredients present in the formulation of SBP, which acted on 471 potential targets. A total of 226 target genes of RVE were obtained from the GeneCards database. The protein-protein interaction (PPI) network showed that there was a close interaction between 44 common targets of SBP and RVE. The results of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis showed that SBP acted on RVE through various inflammatory pathways and the intestinal immune network. Subsequently, we investigated the effect of SBP on TLR4/MyD88/NF-κB signaling pathway in vitro. After infection with RV- SA11, the expression of TLR4, MyD88, and NF-κB mRNA and protein increased significantly, which could be abolished by SBP treatment. In addition, the IL-1β, TNF-α, IL-6, and IFN-β levels increased markedly in Caco-2 cells infected with RV-SV11. Treatment with SBP partly reversed the changes of IL-1β, TNF-α, and IL-6, while further increased the level of IFN-β. In conclusion, our study revealed that SBP can significantly inhibit rotavirus replication and proliferation in vitro. The antiviral effect may be related to the regulation of the TLR4/MyD88/NF-κB signaling pathway, followed by the down regulation of inflammatory cytokines and up regulation of IFN-β induced by rotavirus.
Highlights
Rotavirus (RV), a double-stranded RNA virus belonging to the family Reoviridae, is the main cause of acute gastroenteritis in infants worldwide
Antibodies against Toll-like receptor 4 (TLR4), MyD88, and NF-κB p65, primary antibodies, and β-actin were obtained from Abcam (Cambridge, United Kingdom)
Enzyme-Linked Immunosorbent Assay (ELISA) kits for TNF-α, IL-1β, IL-6, and IFN-β were purchased from Boster Biological Technology Co., Ltd., China
Summary
Rotavirus (RV), a double-stranded RNA virus belonging to the family Reoviridae, is the main cause of acute gastroenteritis in infants worldwide. In 2016, more than 258 million children younger than 5 years were infected with rotavirus with an annual incidence of 0.42 cases per child (Troeger et al, 2018). RV is the leading infectious cause of diarrhea related deaths in children under 5 years old in the world; it accounts for 37% of the total number of diarrhea related deaths (Sestak, 2018). There were about 2,15,000 children who died of rotavirus enteritis in 2013; out of which more than 95% occurred in African and Asian countries (Tate et al, 2016).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.